AG
PCVX icon

Algert Global’s Vaxcyte PCVX Stock Holding History

Algert Global’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30M Buy
515,343
+151,359
+42% +$8.22M 0.36% 26
2026
Q1 		$21.2M Buy
363,984
+296,545
+440% +$16.1M 0.32% 54
2025
Q4 		$3.11M Sell
67,439
-104,710
-61% -$4.68M 0.05% 592
2025
Q3 		$6.2M Buy
172,149
+22,570
+15% +$748K 0.1% 350
2025
Q2 		$4.86M Buy
149,579
+93,400
+166% +$3.06M 0.1% 340
2025
Q1 		$2.12M Sell
56,179
-16,890
-23% -$1.35M 0.05% 584
2024
Q4 		$5.98M Buy
73,069
+33,777
+86% +$3.35M 0.14% 225
2024
Q3 		$4.49M Buy
39,292
+4,540
+13% +$409K 0.12% 289
2024
Q2 		$2.62M Buy
34,752
+21,442
+161% +$1.46M 0.09% 379
2024
Q1 		$909K Sell
13,310
-1,080
-8% -$74.8K 0.04% 636
2023
Q4 		$904K Sell
14,390
-10,400
-42% -$540K 0.04% 644
2023
Q3 		$1.26M Buy
24,790
+2,790
+13% +$138K 0.06% 513
2023
Q2 		$1.1M Buy
22,000
+163
+0.7% +$7.73K 0.05% 627
2023
Q1 		$818K Buy
+21,837
New +$926K 0.04% 703
2022
Q4 		– Sell
-45,505
Closed -$1.09M – 1243
2022
Q3 		$1.09M Buy
45,505
+16,181
+55% +$410K 0.07% 504
2022
Q2 		$638K Buy
29,324
+19,850
+210% +$459K 0.05% 674
2022
Q1 		$229K Sell
9,474
-3,292
-26% -$71.9K 0.02% 1020
2021
Q4 		$304K Buy
12,766
+1,480
+13% +$34.4K 0.04% 725
2021
Q3 		$286K Buy
+11,286
New +$274K 0.04% 780

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Algert Global's PCVX Position: Q2 2026 in Review

Algert Global increased its Vaxcyte (PCVX) stake by 42% in Q2 2026, buying an estimated $8.22M and bringing the position to 515,343 shares worth $30M. The position accounts for 0.36% of the portfolio, ranked #26.

Algert Global first reported a position in PCVX in Q3 2021 and has held it in 19 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Algert Global held 515,343 shares of Vaxcyte worth $30M as of Q2 2026.
  • Algert Global bought 151,359 Vaxcyte shares in Q2 2026, an estimated $8.22M.
  • Vaxcyte made up 0.36% of Algert Global's portfolio in Q2 2026, its #26 holding.
  • Algert Global first reported a position in Vaxcyte in Q3 2021 and has held it in 19 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.